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The influenza virus NS1A 
binding protein gene modulates 
macrophages response 
to cytokines and phagocytic 
potential in inflammation
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Macrophages show remarkable phenotypic plasticity in response to environmental signals. Although 
it is generally less considered, cytoskeletal changes in macrophages influence their phenotype, 
including phagocytosis and secretion of soluble cytokines. Influenza virus NS1A‑binding protein 
(Ivns1abp) belongs to the Kelch family of proteins that play a central role in actin cytoskeleton 
dynamics by directly associating with F‑actin and by protecting against actin derangement. Due 
to its role in cytoskeleton preservation, the Ivns1abp gene might be a critical regulator of the 
macrophage phenotype and function under inflammatory conditions. In this study, we determine 
that the modulation of the Ivns1abp gene in macrophages could modify resistance to macrophages 
against inflammation and maintain functional phagocytosis. Our results indicate that inflammatory 
insults inhibit the Ivns1abp gene, whereby phagocytosis is inhibited and the ability of macrophages 
to induce proliferation and repair of damaged cells is compromised. Furthermore, our results show 
that inflammatory insults alter the activity of the transcription factor c‑myc, a factor which directly 
modulates the expression of the Ivns1abp gene. In conclusion, this study demonstrates a central role 
of lvns1abp in promoting and preserving a reparative macrophage phenotype and resistance to this 
inflammatory environment.
Macrophages exhibit a wide heterogeneity and functional plasticity, which is reflected in their expression of dif-
ferent phenotypes in response to microenvironmental signals. They can be activated conventionally by microbial 
wall lipopolysaccharides (LPS) and Th1-type cytokines, triggering the activation of a pro-inflammatory pheno-
type or, alternatively, in the presence of Th-2 type cytokines such as IL-4, IL-13 or IL-10, inducing the alternative 
phenotype  polarization1. The biphasic effect of macrophages during damage/repair in tissues is attributed to a 
macrophage switch towards an alternatively activated phenotype, leading to the suppression of the inflammatory 
response and the induction of the repair  phase2. Latter investigations suggest that targeting macrophage activation 
and phenotype can lead to new therapies in the treatment of acute and chronic diseases such as obesity, insulin 
resistance or  asthma3,4. Along the same lines, our group has demonstrated the therapeutic effect of macrophage-
cell therapy in different chronic and acute kidney  diseases5–7.
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Apart from the cytokine stimuli, changes in the cell morphology by themselves or as a function of the stiffness 
of the substrate are also critical for the pro-inflammatory vs. pro-healing regulatory state of  macrophages8,9. In 
recent years, it has been demonstrated that modifications in cellular shape influence the transcription of gene 
programs associated with the macrophages, mechanical signals on transcription factor activity and therefore 
on genetic pathways associated with phenotype  polarization10–12. Today, due its complex nature, macrophage 
polarization remains a subject of much debate and controversy. Some studies using engineered cell culture 
substrates to control cell shape determined that elongation of macrophages and stabilization of the cytoskeleton 
promote a pro-healing macrophage  phenotype9,11,13. Nevertheless, novel biochemical or molecular approaches 
that expand the knowledge of the underlying mechanisms are urgently needed. The task now is to discover new 
components that induce genes related to cytoskeleton dynamics and regulation.
The influenza virus NS1A-binding protein (Ivns1abp) gene encodes the actin binding protein, Nd1, which 
belongs to the Kelch family of proteins. These proteins play an important role in the organization of actin 
cytoskeleton dynamics by stabilizing actin filaments through their association with F-actin mediated by Kelch 
 repeats14. Both Nd1-S and L cross-link actin filaments, protect against the actin derangement, and play a critical 
role in fundamental cellular functions such as cell division, cell locomotion and phagocytosis. Indeed, it has 
been reported that overexpression of Nd1-S modifies cell cycle progression in  fibroblasts15. These features make 
Ivns1abp an important regulator of cytoskeleton stability and, consequently, a potential critical regulator of the 
macrophage phenotype.
Ivns1abp gene promoter is regulated by c-myc16, among others,. In turn, c-myc is modified by a variety of 
downstream signalling pathways of inflammatory  cytokines17–19, and is also involved in the induction of a large 
set of genes during alternative macrophage activation, by way of either direct or indirect  interaction20.
Since, on the one hand, the Ivns1abp gene takes on an important role in both the coordination of actin 
cytoskeleton dynamics as well as cell shape and, on the other hand, modifications of the macrophage cytoskeleton 
can regulate their pro-inflammatory state versus the pro-healing active state, in this study we investigated the 
contribution of the Ivns1abp gene in the control of the actin cytoskeleton of macrophages during inflammation 
and the role of this gene in macrophage polarization. We also explored the role of transcription factor c-myc in 
this context. We further tested the potential therapeutic effect as cell therapy against renal I/R injury.
Material and methods
Animals. All procedures were approved and carried out under the supervision of our institution’s Ethics 
Committee for Animal Experimentation (Comitè d’Ética d’Experimentació Animal, CEEA) and in accordance 
with the approved European Union guidelines for the handling and care of laboratory animals. We used Sprague 
Dawley rats (225–250 g) (Charles River, France) for cell therapy studies involving ischemia/reperfusion injury. 
Animals were given free access to water and a standard laboratory chow diet. In vivo experimental groups  
(n = 5 per group): Animals were anesthetized with isoflurane and placed in a supine position with body tem-
perature maintained at 37ºC. The abdominal area was covered to minimize dehydration. After laparotomy and 
dissection of renal pedicles, bilateral ischemia was induced by occluding the renal pedicles with an atraumatic 
microvascular clamp for 45 min. The clamps were removed during reperfusion. Sham: control group without 
infusion of macrophages; Sham + Mϕ-Ivns1abp: control group with adoptive transfer of ex-vivo–modified mac-
rophages overexpressing Ivns1abp; ischemia/ reperfusion (I/R): 45 min of bilateral ischemia followed by 24 h 
of reperfusion; I/R + Mϕ-Ivns1abp: I/R group with adoptive transfer of ex vivo–modified macrophages overex-
pressing Ivns1abp; I/R + Mϕ-βgal: I/R group injected with β-gal macrophages. At 24 h of reperfusion, blood was 
collected for creatinine and blood urea nitrogen analysed. In addition, kidneys were harvested and snap-frozen 
at -80ºC, set in paraformaldehyde, or embedded in an optical coherence tomograph and frozen in liquid nitro-
gen. For the adoptive transfer, macrophages were smoothly transferred to a culture tube, and maintained in PBS 
until injection into the animal. We injected the cells (10 × 106 cells per rat, via direct intravenous puncture in the 
inferior vena cava) 1 h after reperfusion induction as previously performed by our  group5.
Primary macrophage generation. Rat bone marrow-derived macrophages (BMDM) were isolated from 
Sprague Dawley rats (Charles River, Barcelona, Spain) by aspiration of the femur. They were then re-suspended 
in DMEM, supplemented with 10% FCS, 10 ng/ml GM-CSF (Peprotech, Hamburg, Germany), 100 U/ml peni-
cillin, and 100 µg/ml streptomycin, and kept in non-adherent culture flasks for 7 days. Macrophages were subse-
quently isolated by adherence and purity was determined by ED1 and CD11b expression.
NRK‑52e culture. The renal epithelial cells NRK-52e (European Collection of Cell Culture, Salisbury, UK) 
were cultured in Dulbecco’s modified Eagle Medium (DMEM) with high glucose, 15 mM Hepes and L-glu-
tamine, supplemented with 100 U/ml of penicillin, 100 µg/ml of streptomycin, and 10% FCS. Cells were kept 
in a humidified atmosphere with 5%  CO2 in air at 37  °C and were passaged every second day using 1  mM 
EDTA/0.025% trypsin (Gibco). Cell cycle arrest was performed as indicated previously by our  group21. As 
described, 50 µM colchicine (Sigma, Madrid, Spain) was added to NRK-52e cells for 24 h to decrease prolifera-
tion without compromising viability. Colchicine was removed, fresh medium was added and cell viability was 
checked. Individual stimuli were applied for another 24 h.
Renal epithelial cell/macrophage co‑culture. Co-culture conditions of NRK-52e cells and primary 
macrophages at a ratio of 1:1.5 was performed for 24 h in 6-well plates using transwell inserts (Corning, Madrid, 
Spain) to ensure spatial separation. NRK 52e cells (bottom) were treated with colchicine for 24 h and washed 
twice with PBS prior to co-culture with primary bone-marrow-derived macrophages (BMDM) seeded into the 
3Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:15302  | https://doi.org/10.1038/s41598-020-72342-7
www.nature.com/scientificreports/
insert of the transwell  system21. At the end of the culture, cells and supernatant were processed separately for 
further determinations.
Preparation of macrophage conditioned media. For the generation of conditioned media, cells were 
serum-starved for 24 h. Primary macrophages were then transfected either with siRNA to knockdown Ivns1abp 
(shIvns1abp) or with non-targeting shRNA. After removing the supernatant, macrophages were washed twice 
with PBS, and incubated for another 24 h with DMEM without serum. This supernatant was termed condi-
tioned medium (CM) and subsequently used in further experiments as indicated. CM was harvested by way of 
centrifugation (13.000 × g, 10 min) and filtered through 0.2 μm pore filters (Millipore, Madrid, Spain) to remove 
large particles.
Adenoviral transfection. Adenoviral vectors were used to transduce BMDM ex vivo. shRNA transfec-
tion as well as adenoviral vectors carrying cDNA encoding recombinant Ivns1abp, β-galactosidase or GFP was 
performed to the manufacturer’s recommended protocol EBioFocus DPI BV, Leiden, Netherland for shRNA). 
Adenoviral vectors for β-galactosidase (Adβ-gal) were kindly provided by Dr David Kluth and Dr Jeremy 
Hughes (MRC Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh, UK). The 
adenoviral vector carrying the cDNA encoding recombinant Ivns1abp was elaborated, amplified, and purified 
by ViraQuest, Inc (North Liberty, IA, USA). We used transduction medium containing (DMEM (high glucose)/
F12 + GlutaMax 2% FBS), 1.6 µl of poly-l-lysine and 800 μl of virus according to its optimum dose (MOI 100 
for sh-Ivns1abp and MOI 250 for Ivns1abp, β-gal, and GFP). Cells were incubated for 24 h at 37ºC in a  CO2 
incubator. Quantification of ivns1abp expression was performed by real time qRT-PCR at 24 h post transfection.
In vitro experimental groups. For BMDMs; Resting Mϕ: Untreated BMDMs; Mϕ sh-Ivns1abp: BMDMs 
transfected with a vector that silences Ivns1abp expression; Mϕ non-targeting shRNA; shRNA targeting eGFP; 
Mϕ + Ivns1abp: vector over-expressing Ivns1abp gene; Mϕ + cytokines: BMDMs treated with cytokine cocktail 
(60  ng/ml TNF-α, 100U/ml IFN-γ); Mϕ + Ivns1abp + cytokines: Ivns1abp over-expression and treatment for 
24 h with cytokine cocktail; Mϕ + βgal: Transduction with adenoviral control vector β-galactosidase; Mϕ + F4: 
treatment for 24 h with 100 μm of the c-myc inhibitor 10058-F4. For epithelial cells; Control: untreated cells; 
NRK: Epithelial cells were treated with 50 μM of colchicine for 24 h; NRK + Mϕ: cells treated with colchicine 
were co-cultured with unstimulated BMDM for 24 h; NRK + Mϕ non-targeting shRNA or with a vector that 
silences the expression of Ivns1abp gene (NRK + Mϕ sh-Ivns1abp).
Scratch wound assay. For scratch wound assays, 1 × 105 NRK-52e cells were seeded in 24-well culture 
plates until 80% confluence was obtained. After 24 h, cells were starved for an additional 16 h before the scratch 
was carried out with a small pipette tip. Detached cells were removed by washing with PBS. Stimulation was 
performed with conditioned medium for 24 h.
Phagocytosis assay. In order to examine the phagocytic function of BMDM cells, phagocytosis assay tests 
were performed. BMDM cells after being differentiated for 7 days and seeded to 6-well plates, were stimulated 
for 24 h, either with DMSO (1:1,000) or with TNF-a (60 ng/ml, 3 μl/ well from stock 20 μg/ml), IFN-y (100 U/
ml, 1 μl/ Stock 100 U/μl) or c-myc Inhibitor (1:1,000, 100 μM, 1 μl/well). The conditioned medium was removed 
and FCS free media with 10 μM CMRA was added and incubated with the cells for 15–45 min. Subsequently, the 
working dye solution was replaced with fresh, pre-warmed medium and cells were incubated for another 30 min 
at 37 °C. Fluorescent carboxylate beads (2 μm diameter, Invitrogen, Carlsbad, CA) were incubated with the cells 
for a maximum of 120 min. Samples, after the different time periods of contact with fluorescent carboxylate, 
were washed extensively with PBS and 500 μl of accutase per well for 5 min in order to detach the cells for flow 
cytometry analysis. Samples were placed in FACS tubes containing 1–2 ml of PBS to stop accutase reaction. 
500 μl of the sample was used for RNA analysis while the remainder was centrifuged (5 min, 500 g, 4 °C) to 
remove PBS and accutase and blocked for 15 min using Fc Block MIX (0.5 μl FcBlock in PBS). After blocking, 
F4/80 Antibody PBS mix (1 μl/ sample in 100 μl PBS) was added and cells were analyzed by flow cytometry. For 
microscope visualization, cells were washed with PBS and fixed with 3.7% formaldehyde in PBS for 15 min at 
room temperature. Cells were washed with PBS and incubated with Hoechst Farbstoff (0.2 μg/ml 1:5,000) for 
7 min. After washing with PBS and water, samples were mounted with vectashield and viewed using a Leica TCS 
NT laser microscope (Leica Microsystems, Wetzlar, Germany).
Phalloidin staining. For the in vitro experiments, cells were fixed in 3.7% paraformaldehyde for 10 min, 
washed with PBS, permeabilized with acetone for 5 min on ice, and blocked with goat serum (Sigma, Madrid, 
Spain) for 1 h at room temperature. Cells were washed twice with PBS and incubated with Alexa Fluor 568 phal-
loidin staining (Invitrogen) 0.5 Units/100 μl l in 1% PBS/BSA buffer for 30 min at room temperature. After wash-
ing with PBS, samples were incubated with DAPI solution (0.2 μg/mL) (Sigma-Aldrich) for 5 min and washed 
three times with PBS. The preparation was mounted with mowiol (Calbiochem, Madrid, Spain) and cells were 
viewed using a Leica TCS NT laser microscope (Leica Microsystems, Wetzlar, Germany). In the case of kidney 
tissue, one-half of the kidney was embedded in OCT and frozen in liquid nitrogen without prior fixation. Five-
micrometer cryosections were fixed in 4% buffered formaldehyde for 10 min and then permeabilized with PBS 
containing 0.1% Triton X-100 and 1% BSA for 30 min. For actin visualization, the slides were incubated with 
Alexa Fluor 568-phalloidin (dilution, 1:40, Molecular Probes, Eugene, OR) in PBS with 1% BSA for 30 min. 
Slides were washed three times for 15 min with PBS and finally mounted using mowiol. Confocal images were 
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taken with a Leica TCS NT laser microscope (Leica Microsystems, Wetzlar, Germany) equipped with a 100 oil-
immersion objective as previously  described22.
SDS‑PAGE and Western blot analysis. For Western blot analysis, cells were scraped off, centrifuged, 
resuspended in lysis buffer (Urea 7 M, Thiourea 2 M, Chaps 4%, Tris 40 mM, PMSF, DTT), and sonicated for 
1 min. Subsequently, protein concentrations were determined with the Bradford method using a commercial kit 
from BioRad. Equal amounts of protein were resolved on 10%-SDS polyacrylamide gels and blotted onto nitro-
cellulose membranes. Unspecific binding was blocked with 5% milk in 0.6% Tween-TBS (TTBS) for 1 h. Primary 
antibody was added in TTBS/5% dry milk and incubated overnight at 4 °C. For protein detection, blots were 
incubated with the secondary antibody in TTBS/5% dry milk, followed by ECL-detection of specific proteins 
using the Quantity One imaging system (Bio-Rad). Equal loading of protein was determined by visual detection 
by incubating the membranes with Ponceau. The sample treatment in the actin Western blot was performed to 
differentiate the F- and G-actin forms. The samples were homogenised in PHEM buffer (60 mM PIPES, 25 mM 
HEPES, 10 mM EGTA, and 2 mM MgCl2, pH 6.9, containing 0.1% Triton X-100, 0.5 mM PMSF, and 0.1 mM 
DTT). The homogenate was centrifuged at 48,000 g during 5 min at 4 °C. The insoluble fraction (cytoskeleton 
associated) was used for Western blot  analysis13.
Total RNA extraction, cDNA synthesis and real time PCR. Total RNA was isolated using the RNeasy 
mini kit following the manufacturer’s protocol (Qiagen, Barcelona, Spain). Thereafter, RNA was eluted in 50 μl of 
RNase-free water. RNA concentrations were calculated from A260 determinations using a Nanodrop ND-1000 
(NanoDrop Technologies, Wilmington, DE, USA. Then, obtained RNA was reverse transcribed by using an 
iScript cDNA Synthesis Kit (Bio-Rad) in a final volume of 20 μl. Quantitative RT-PCRs were performed on a 
Bio-Rad iCycler iQ Real-Time-PCR detection system using either SYBR Green RT-PCR detection Kit (Bio-Rad, 
Madrid, Spain) or pre-validated TaqMan probes (Applied Biosystems, Madrid, Spain) according to manufac-
turer’s instructions. For the design of the primers internet sources such as NCBI, Primer 3 and Operon were 
used. Table 1 shows selected primers used in the study.
Statistical analysis. All data are reported as mean ± SE. Group means were compared with either the Stu-
dents t test or ANOVA for parametric values, P ≤ 0.05 was considered to be statistically significant.
Results
Modulation of Ivns1abp gene in macrophages increases the resistance against inflammation 
and cytoskeleton derangement provoked by cytokines. To explore the impact of the Ivns1abp gene 
on the macrophage cytoskeleton, inflammatory state and reparative capacity, we used a specific adenovirus as 
the RNA interference-based gene silencing technology to knock out Ivns1abp expression.
Table 1.  Primer sequences used in this study.
Gene
(Accession number) Source Primer sequence
GAPDH
(NM_ 008084) Invitrogen
Forward: 5′-TGA-AGC-AGG-CAT-CTG-AGG-C-3′
Reverse. 5′-CGA-AGG-TGG-AAG-AGT-GGG-AG-3′
Ki-67
(NM_001081117) Invitrogen
Forward: 5′-CAG-TAC-TCG-GAA-TGC-AGC-AA -3′
Reverse: 5′-CAG-TCT-TCA-GGG-GCT-CTG-TC-3′
PCNA
(NM_011045) Invitrogen
Forward: 5′-AAT-GGG-GTG-AAG-TTT-TCT-GC-3
Reverse: 5′-CAG-TGG-AGT-GGC-TTT-TGT-GA-3′
Mannose Receptor
(NM_008625) Invitrogen
Forward: 5′-CAG-GTG-GCT-TAT-GGG-ATG-TT-3′
Reverse: 5′-GAG-TTG-TTG-TGG-GCT-CTG-GT-3′
TNF-α
(NM_013693.3) Invitrogen
Forward: 5′-GAA-CTG-GCA-GAA-GAG-GCA-CT-3′
Reverse: 5′-GGT-CTG-GGC-CAT-AGA-ACT-GA-3′
iNOS
(NM_010927.3) Qiagen QuantiTect Primer Assay for SybrGreen detection
IL-10
(NM_010548) Qiagen QuantiTect Primer Assay for SybrGreen detection
Ivns1abp
(NM_001039511.1)
Applied
biosystems TaqMan Gene Expression Assay
c-myc
(AFO76523)
Applied
biosystems TaqMan Gene Expression Assay
GAPDH
(NM_008084.2)
Applied
biosystems TaqMan Gene Expression Assay
Rn_PCNA
(NM_022381) Invitrogen
Forward: 5′-AGG-ACG-GGG-TGA-AGT-TTT-CT-3′
Reverse: 5′-CAG-TGG-AGT-GGC-TTT-TGT-GA-3′
Rn_Ki-67
(XM_00105622) Invitrogen
Forward: 5′-AGA-CGT-GAC-TGG-TTC-CCA-AC-3′
Reverse: 5′-ACT-GCT-TCC-CGA-GAA-CTG-AA-3′
Rn_GAPDH
(NM_017008) Invitrogen
Forward: 5′-CCG-CCA-ATG-TAT-CCG-TTG-TG-3′
Reverse: 5′-TAG-CCC-AGG-ATG-CCC-TTT-AGT-3′
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Figures 1 and 2 show the Ivns1abp-specific down-regulation effects in macrophages. The organization of 
cytoskeletal F-actin was visualized by immunofluorescence and further determined by F-actin and G-actin 
fractions. The images show a round shape in resting cells with bright fluorescent staining and homogenous 
distribution of the staining along the cytoplasm. Down-regulation of Ivn1sabp induced irregular shaped cells, 
and evident disruption of actin filaments with brightness dissipation and the presence of F-actin fibres in clus-
ters showing a non-homogeneous distribution of the fluorescence along the cytoplasm (Fig. 1a). The observed 
changes in actin filament were confirmed by WB analysis. Upon Ivns1abp knockdown a loss of F-actin and a gain 
of G-actin fraction was observed (Fig. 1b). Since cell shape is related to macrophage phenotype, we analysed the 
transcription of pro-inflammatory and anti-inflammatory markers. iNOS and TNF-α levels increased, whereas 
the anti-inflammatory IL-10 and mannose receptor significantly decreased (Fig. 1c). Thus, the results indicate 
that the Ivns1abp gene is implicated in morphology, shape as well as phenotype activation in macrophages. The 
non-targeting shRNA group remained unaffected. The additional data 1a shows the expression of Ivns1abp gene, 
demonstrating the efficiency in downregulation by expressing only 12–15% of the Ivns1abp gene compared to 
the level of expression of untreated macrophages.
With two different tests, we then analysed the macrophage cytoskeleton modifications based on repair func-
tion. First, we tested the reparative capacity of macrophage supernatants using a cellular scratch model (Fig. 2a), 
and second, we determined the ability to induce proliferation by enhancing Ki-67 and PCNA mRNA expression 
in a co-culture with renal epithelial cells (Fig. 2b). In the scratch test, we added different macrophage supernatants 
to damaged (scratched) renal epithelial cells for 24 h and we observed that the supernatant of the Ivns1abp-
deficient macrophages lost its ability to induce repair compared to the that of the standard control macrophage 
or non-targeting shRNA macrophage supernatant capacity. In the case of the co-culture test, epithelial cells were 
pre-treated overnight with colchicine to provoke cell cycle arrest, a model that our group had already established 
 beforehand21. Epithelial cells were washed after colchicine exposure and were either left untreated (control) or 
were co-cultured in a transwell system with macrophages for an additional 24 h. Data depicts that colchicine 
treatment by itself considerably decreased the mRNA expression of the proliferative markers PCNA (Fig. 2b, 
upper panel) and Ki-67 (Fig. 2b, lower panel) of the epithelial cells compared to control cells. Co-culture with 
control macrophages or macrophages transfected with non-targeting shRNA positively re-induces the expression 
of these markers, demonstrating the capacity of macrophages in the re-establishment of the epithelial cell-cycle. 
However, co-culture with macrophages transduced with sh-Ivns1abp did not promote the activation of the 
proliferative markers, indicating that the reparative and proliferative capacity of macrophages in epithelial cells 
is dependent on, at least in part, Ivns1abp gene activation.
In order to study whether this gene plays a role in macrophage phenotype and the response to inflammation, 
we generated Ivns1abp-overexpressing macrophages and treated them with pro-inflammatory cocktail (TNF-α 
and IFN-γ), widely described experimentally as pro-inflammatory  stimuli23–25. Pro-inflammatory cytokines 
showed the ability to modulate the expression of the Ivns1abp gene as well as the protein in both primary 
macrophages and in those with Ivns1abp overexpression. (Fig. 3a,b). Some experimental variations may appear 
between primary cells, but the levels of expression of Ivns1abp protein in resting cells and b-gal control cells are 
low. Although the modulatory action, we tested whether the up-regulation of Ivns1abp induced an anti-inflam-
matory phenotype, cytoskeleton preservation and whether this provided resistance to inflammatory cytokines. 
Ivns1abp-upregulated macrophages responded to cytokine stimulation by maintaining the expression of high 
levels of anti-inflammatory markers (mannose receptor and IL-10) and low levels of pro-inflammatory markers 
(TNF-α and iNOS) showing resistance to the inflammatory insult (Fig. 3c). The morphology and shape of the 
cells are displayed in Fig. 3d; macrophages transfected with Ivns1abp modifies the round shape and the F-actin 
distribution found in resting cells. The morphology became elongated, flattened and more spread out. F-actin 
appears organized and visualized into stress fibers covering the whole cytoplasm. By contrast, cytokine adminis-
tered to resting cells promoted a less elongated shape, a generally lower intensity of the brightness of the staining, 
and stress fibers were observed to be discontinuous and disorganized. Intense clusters also appeared around 
the nucleus. The effect of cytokine treatment is attenuated when Ivns-1abp is upregulated and, although the 
intensity of the stain decreases and the morphology is modified to some degree, the cells preserve the elongated 
morphology and the continuous stress fibers along the cytoplasm still remain. These observations indicate that 
the Ivns1abp over-expression in macrophages mitigates the effect of cytokines and promotes anti-inflammatory 
status.
The efficiency of the transduction is showed in the additional data 1b.
In order to confirm that other inflammatory insults have a similar effect on the Ivns1abp transcription, we 
used LPS as a pro-inflammatory inducer. Similarly, both the cytokine cocktail and LPS caused the downregulation 
of Ivns1abp (Fig. 4a). Interestingly, the inhibition of its transcription factor c-myc, was also clear (Fig. 4b). The 
relation between pro-inflammatory stimulus and c-myc regulation in macrophages is well  described26,27. In order 
to explore the relationship between Ivns1abp and c-myc in our settings, we used 10058-F4, a c-myc inhibitor that 
prevents transactivation of c-myc target gene expression. Figure 4c shows that macrophages treated with c-myc 
inhibitor, present a significant decrease in the levels of Ivns1abp expression compared to the those of the control 
group, indicating the ability of c-myc to directly modulate Ivns1abp expression. This expression is also decreased 
in macrophages over-expressing Ivns1abp and treated with cytokines or with c-myc inhibitor. The effect of the 
inhibitor on Ivns1abp protein expression is shown and quantified in the additional data 1c.
To test if the c-myc-dependent modulation of Ivns1abp induces direct cytoskeleton destabilization, we per-
formed phalloidin staining in control macrophages and macrophages treated with 10058-F4 (Fig. 4d). The rep-
resentative pictures show that control cells displayed a round shape and normally-distributed actin. However, 
groups treated with c-myc inhibitor display a change in the morphology and shape of the cells. The F-actin stain 
was not homogenously distributed and some more intense staining appeared as clusters with tightly packed 
texture, but no long stress fibers were detected.
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Figure 1.  Representative images of (a) phalloidin staining of non-treated BMDM, BMDM silenced for the 
Ivns1abp gene or transduced with non-targeting shRNA. Knockdown of Ivns1abp causes loss of the stress fibers 
in the cytoskeleton and the consequent formation of actin clusters. Original magnification 40×. Bar = 25 μm (b) 
Western blot for the cytoskeleton-associated fraction of actin corresponding to F-actin (F, filamentous) versus 
G-actin (G, globular) (cropped blot). (c) Expression of pro and anti-inflammatory markers in the described 
groups. The down regulation of gene expression induces macrophages to adopt a pro-inflammatory state. Data is 
represented as mean ± SEM. *p < 0.05 versus Resting Mφ; n = 5.
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Figure 2.  (a) Representative pictures of the ability of the macrophage-conditioned medium promote migration 
and repair of the epithelial cells after a mechanical damage. The different conditioned medium was exposed to 
the epithelial cells during 24 h after the scratch Representative images of 5 experiments. Original magnification 
20×. Bar = 75 μm (b) Expression of the proliferation markers PCNA and Ki-67 of NRK-52e renal epithelial cells 
treated with colchicine to arrest cell cycle and after co-culture with untreated or Ivns1abp-silenced macrophages. 
Data is represented as mean ± SEM. *p < 0.05 versus NRK + Col + Mφ; n = 5.
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Figure 3.  (a) Expression of Ivns1ap gene and (b) and western blot for Ivns1abp and GAPDH on macrophages. 
Protein bands are at the expected size of 70 KDa for Ivns1abp and 36 kDa for GAPDH (cropped blot). Right 
panel, densitometric analysis ratio of protein bands. (c) Expression of pro-inflammatory (TNF-α, iNOS) and 
anti-inflammatory markers (IL-10 and Mannose Receptor) in macrophages transfected with Ivns1abp and 
treated with pro-inflammatory stimulus (cytokine cocktail). Data is represented as mean ± SEM n = 5. *p < 0.05 
versus Resting Mφ; + p< 0.05 versus Mφ + Ivns1abp (d) Representative pictures of phalloidin staining of 
macrophages treated with cytokines and macrophages over-expressing Ivns1abp with or without cytokines 
treatment. Original magnification 40×. Bar = 25 μm.
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Figure 4.  Ivns1abp (a) and c-myc expression (b) in resting macrophages or treated with pro-inflammatory 
stimulus cytokines cocktail (TNF-α and IFN-γ) or LPS. Data is represented as mean ± SEM n = 5. * p < 0.05 
versus Resting Mφ (c) Expression of Ivns1abp in macrophages treated with or without cytokines and c-myc 
inhibitor. Data is represented as mean ± SEM. *p < 0.05 versus Resting Mφ; +p < 0.05 versus Mφ + Ivns1abp n = 5 
(d) Representative images of phalloidin staining of resting macrophages and macrophages treated with c-myc 
inhibitor. Original magnification 40×. Bar = 25 μm.
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Altogether, these results demonstrate that cytoskeleton disorganization induced by proinfammatory stimu-
lusis modulates ivns1abp gen.
c‑myc and Ivns1abp modulate macrophage resistance to cytokines and induce functional 
phagocytic response. In order to find out if the changes in the cytoskeleton also affected the phagocytic 
capacity, we performed a phagocytosis assay using FluoSpheres Carboxylate-Modified Microspheres, 2.0 µm. 
Macrophages were stained with F4/80-PE-Cy7 antibody and were analysed by flow cytometry at different time 
points. Figure 5a shows the phagocytosis results in the different groups with or without Ivns1abp overexpression. 
The results of the kinetics show that both the cytokines and the c-myc inhibitor, decrease the phagocytic capac-
ity compared to their respective controls. It should also be noted that the over-expression of Ivns1abp increases 
the phagocytic capacity of macrophages despite the presence of cytokines or c-myc inhibitor. Figure 5b,c shows 
representative images of the phagocytosis during the assay. The phagocytosed beads could be detected in the 
cytoplasm of the cells by the change in size and colour. The white arrows indicate the phagocytic beads that 
are displayed small and bright inside the cell. On the other hand, the unphagocytosed beads can be identified 
by their larger size and by their intense blue colour outside the cells. The image demonstrates that overexpres-
sion of Ivns1abp increases the quantity of the phagocytized beads independently of the treatment but from 
them the phagocytosis is especially active in resting macrophages while pro-inflammatory cytokines or c-myc 
inhibition decrease it. These results indicate that both factors act on the reduction of the phagocytic capacity in 
macrophages.
Over‑expressing Ivns1abp macrophage‑cell therapy preserves the renal cytoskeleton and 
improves renal function against I/R insult. We already demonstrated that cell therapy with modified 
macrophages ameliorate kidney damage in different experimental renal pathologies by decreasing the inflam-
matory  scenario5–7. Given the properties of Ivns1abp-macrophages in actin cytoskeleton stability and the resist-
ance against inflammatory insults, we therefore investigated whether cell therapy with these modified mac-
rophages preserve kidney function and epithelial integrity against the inflammatory damage associated with I/R 
injury. Figure 6 shows renal function and renal tubule integrity after I/R. Blood urea nitrogen and creatinine 
(Fig. 6a) at 24 h of reperfusion are increased, thus indicating a decrease in renal function. Adoptive cell transfer 
of Ivns1abp-over-expressing macrophages to I/R prevented renal dysfunction measured by serum creatinine and 
BUN compared to the I/R group. In contrast, the administration of the control βgal-adenovirus transduced mac-
rophages did not show significant amelioration in these parameters compared to the I/R group. Thus, BMDMs 
over-expressing Ivns1abp were highly protective against the loss of kidney function. Cytoskeleton images of 
renal tubules are shown in Fig. 6b. Phalloidin staining in Sham groups show a clear delimitation and integrity in 
the epithelial tubule and the villi, which are clearly visualized in the lumen of the tubules. We observed similar 
images of cytoskeleton pattern in the animals with adoptive transfer of up-regulated macrophages. However, in 
I/R group, the villi are less apparent, suggesting that they are lost. These results indicate the capability of this cell 
therapy to prevent actin cytoskeletal alterations.
Lastly, we verified whether the observed tissue preservation was also due to inducing greater repair and 
proliferation of the epithelial tubules. To this aim we measured the specific markers stathmin and proliferation 
cellular nuclear antigen (PCNA) protein levels by immunofluorescence and the mRNA expression by qRT-PCR. 
Stathmin (green) staining and proliferation of the cellular nuclear antigen (PCNA) (red) (Fig. 7a) as well as the 
mRNA levels (Fig. 7b) reflects a clear positive increase of the proliferative markers in the tubule cells especially 
in the animals treated with Ivns1abp-macrophage cell therapy, indicating the ability to potentiate proliferation 
and repair. The repair after the I/R injury of the Ivns1abp-macrophages is evidenced by the decrease in tissue 
inflammation. This is reflected by the increase of the production of the anti-inflammatory cytokine IL-10 and the 
non-increase in TNF-α expression (Fig. 7c) in these animals. Thus, these results showed the ability of BMDMs 
overexpressing Ivns1abp in bolstering repair in the kidney against I/R.
Discussion
The alternative phenotype of macrophages is crucial for stimulating tissue repair and regeneration. But this 
phenotype is strongly influenced by cytokines and by the inflammatory environment, which diminishes or even 
eliminates the capacity of repair. Therefore, factors that are capable of eluding cytokine attack and/or promoting 
resistance to cytokines or to pro-inflammatory insults should be considered in a repair scenario. In this study, 
we focused on the modulation of the Ivns1abp gene in macrophages, which was revealed as an important target 
due to its ability to induce resistance to inflammation. Ivns1abp belongs to the Kelch  family14 and although there 
are not many studies focusing specifically on the function, they indicate that it is multifunctional, since it is 
involved in signal  transduction28, splicing and stability of  proteins29,30 and stabilization of actin  filaments14. Our 
results show that down-regulation of Ivns1bp impacts the actin cytoskeleton of macrophages, directly changing 
its shape and morphology and promotes its pro-inflammatory state.
The relationship between macrophage morphology and phenotype has been previously studied in different 
types of macrophages and experimental situations. Heinrich et al. focused on investigating the morphologic, 
phenotypic, and transcriptomic characteristics in canine blood-derived macrophages in vitro31. However, most 
studies have focused on  murine11,32,33 or human  origin34,35 both in pathological models and in models based on 
biomaterials and  stiffness8,11,13,35. In all of them the relationship between changes in morphology and different 
phenotypes is demonstrated. In our study we showed that the activation or inactivation of the Ivns1abp gene 
is essential in this relationship during inflammation. Our study reflects that a pro-inflammatory environment 
inhibits the Ivns1abp gene in macrophages, so that primary functional roles such as phagocytosis or the abil-
ity to induce proliferation are compromised. Other features of Ivns1abp inhibition are changes in cell shape, 
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Figure 5.  (a) Kinetics of the phagocytosis assay at different time points using Carboxylate-Modified 
Microspheres in non-transfected macrophages (left) in macrophages overexpressing Ivns1abp (right) and all 
groups merged in one graph (down). Data is represented as mean ± SEM. n = 5. *p < 0.05 versus Mφ at each 
time point, +p < 0.05 versus Mφ_Ivnsapb at each time point, ♯♯♯p < 0.05 significant in all overexpressed versus 
non-overexpressed groups at this time point. ♯♯p < 0.05 Mφ and Mφ + F4 versus corresponding over-expressed 
groups in the time point. Representative fluorescent images (right) and overlay with optical view (left) of the 
phagocytosis assay at 60 min in (b) non-overexpressed groups and (c) and in over-expressed groups. White 
arrows point the phagocytic beads. Un-phagocyted beads are detected by larger size and different colour. 
Original magnification 40×. Bar = 25 μm.
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Figure 6.  (a) Creatinine and blood urea nitrogen (BUN) in plasma of Sham, IR groups and adoptive transfer 
of either macrophage transduced with β-gal or Ivns1abp. Data is represented as mean ± SEM n = 5. *p < 0.05 
versus Sham; +p < 0.05 versus I/R. (b) Representative images of F-actin visualization by phalloidin of proximal 
renal tubules from cortical kidney sections and analyzed by confocal microscopy in Sham and I/R animals 
with or without cell therapy of macrophages overexpressing Ivns1abp or macrophages transduced with β-gal 
adenovirus. The asterisk indicates the lumen of the tubules. Original magnification 60×. Bar = 10 μm.
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Figure 7.  (a) Immunostaining of stathmin (green) and PCNA (red) expression in renal tissue of Sham and I/R 
animals with or without cell therapy of macrophages overexpressing Ivns1abp or macrophages transduced with 
β-gal adenovirus. Ki-67 and PCNA Original magnification 20×. Bar = 75 μm. mRNA expression tested via qRT-
PCR in total renal tissue homogenates of (b) PCNA and stathmine and (c) IL-10 and TNF-α. qRT-PCR data was 
normalized to the housekeeping gene GAPDH and expressed as arbitrary units of relative expression. Data is 
represented as means ± S.E.M. n = 5; *p < 0.05 versus Sham; + p < 0.05 versus I/R.
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reflecting modifications in the cytoskeleton, and polarization to the pro-inflammatory phenotype. In contrast, 
up-regulation of Ivns1abp induces polarization towards an alternative macrophage phenotype, significantly 
decreases the expression of pro-inflammatory mediators such as TNF-alpha and iNOS, and increases the expres-
sion of anti-inflammatory mediators such as IL-10 and mannose receptor. In addition, inflammatory polarization 
is prevented when encountering a pro-inflammatory environment. In other words, the Ivns1abp modulation 
would produce a change in the macrophage phenotype.
Since the cytoskeleton of macrophages is constantly changing both to adapt to different environments and 
to exert different innate functions, maintaining a stable cytoskeleton in a prolonged manner towards an anti-
inflammatory and repair phenotype in a pro-inflammatory environment could give rise to the acceleration of 
repair and regeneration. In this regard, cell culture substrates designed to control cell shape have revealed that 
cell elongation and a stable cytoskeleton promote a healing phenotype, indicating that alterations in cell shape 
provide integral signals that modulate the polarization of macrophage  phenotypes11. Furthermore, in recent 
years it has been shown that changes in cell shape influence the transcription of the phenotype genetic program 
in different cell  types36 and also in  macrophages9. Active phagocytosis is one of the main functions of alternately 
activated macrophages. These are dynamic processes that are mechanically linked to the rearrangement of actin 
 filaments37. It is a complex process that continues to be studied and where the key challenge remains to under-
stand how the signals affecting the cytoskeleton translate into a rearrangement of actin. In our study, the results in 
phagocytosis showed that an overregulation of Ivns1abp provides macrophages with a higher phagocytic capacity 
despite the presence of cytokines, suggesting that the mechanisms that impact on Ivns1abp in the macrophage 
will have a result in its phagocytic capacity. This is potentially interesting for pathological situations with defi-
cient phagocytosis, such as in therapies against tumors, where the search for therapies continues to this  day38.
By exploring the possible transcription factors that could modulate Ivns1abp in macrophages under inflam-
matory stimuli we focused on c-myc as the main candidate. C-myc is a proto-oncogene with unregulated expres-
sion that is associated with tumor development in mice and  humans39. More recently, it has been shown to be 
involved in the induction of a large set of genes during the activation of alternative macrophages, either by direct 
interaction or indirectly through the induction of the signal transducer and transcription activator-6 (STAT6) 
and PPARγ20. C-myc is also regulated by  cytokines18,19,28. In order to directly test the interaction of this transcrip-
tion factor in Ivns1abp macrophages in a pro-inflammatory context, we evaluated whether cytokines or LPS 
modify the expression of c-myc/Ivns1abp. In addition, in the set of experiments we used the inhibitor c-myc 
10058-F4 that specifically inhibits c-myc-Max interaction and prevents transactivation of the expression of the 
c-myc target gene. With this study, we demonstrated that inflammatory insults alter the activity of the c-myc 
transcription factor, modifying the expression of the Ivns1abp gene. We also confirmed the strong suppression 
of c-myc transcription by the pro-inflammatory stimulus described above by other  authors26,27. Interestingly, 
inhibition of c-myc induced changes in cell morphology and a disruption of actin filaments forming clusters with 
tightly packed texture and a significant decrease in the levels of Ivns1abp expression. Such conclusions indicate 
the ability of c-myc to directly modulate the expression of Ivns1abp in these cells.
Lastly, given the properties of macrophages overexpressing Ivns1abp in actin cytoskeleton stability and resist-
ance to inflammation and following our previous experience in cellular therapy with macrophages in renal 
 pathology5–7, we hypothesized that these macrophages could be used as a treatment for damage associated with 
I/R injury. The experiments revealed that BMDMs that overexpress Ivns1abp were highly protective of renal 
function as well as the epithelial structure of renal tubules preventing mismatches of actin cytoskeleton loss. In 
addition, the repair observed after I/R injury and the decrease in inflammation leads us to postulate BMDMs 
overexpressing Ivns1abp as a potential tool to promote repair in the kidney versus I/R.
In conclusion, in this study we evidenced the central role of the lvns1abp gene in the promotion of alterna-
tive phenotypes and resistance to cytokines and the inflammatory environment, as well as its possible efficacy 
as a cell therapy approach. Our data reveals that pro-inflammation inhibits the Ivns1abp gene in macrophages, 
resulting in the loss of primary functions such as phagocytosis or the ability to proliferate. The consequences of 
Ivns1abp inhibition are also detected in cytoskeletal modifications and polarization to the pro-inflammatory 
phenotype. In contrast, preservation of Ivns1abp may induce an alternative activation of macrophages by pro-
viding resistance to inflammation.
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